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Objectives. We sought to determine the prognostic value of the
admission electrocardiogram (ECG) in patients with unstable angina
and non–Q wave myocardial infarction (MI).
Background. Although the ECG is the most widely used test for
evaluating patients with unstable angina and non–Q wave MI, little
prospective information is available on its value in predicting outcome in
the current era of aggressive medical and interventional therapy.
Methods. ECGs with the qualifying episode of pain were analyzed in
patients enrolled in the Thrombolysis in Myocardial Ischemia (TIMI)
III Registry, a prospective study of patients admitted to the hospital with
unstable angina or non–Q wave MI.
Results. New ST segment deviation >21 mm was present in 14.3% of
1,416 enrolled patients, isolated T wave inversion in 21.9% and left
bundle branch block (LBBB) in 9.0%. By 1-year follow-up, death or MI
occurred in 11% of patients with >21 mm ST segment deviation com-
pared with 6.8% of patients with new, isolated T wave inversion and 8.2%
of those with no ECG changes (p < 0.001 when comparing ST with no
ST segment deviation). Two other high risk groups were identified: those
with only 0.5-mm ST segment deviation and those with LBBB, whose
rates of death or MI by 1 year were 16.3% and 22.9%, respectively. On
multivariate analysis, ST segment deviation of either >21 mm or
>20.5 mm remained independent predictors of death or MI by 1 year.
Conclusions. The admission ECG is very useful in risk stratifying
patients with non–Q wave MI. The new criteria of not only >21-mm ST
segment deviation but also >20.5-mm ST segment deviation or LBBB
identify high risk patients, whereas T wave inversion does not add to
the clinical history in predicting outcome.
(J Am Coll Cardiol 1997;30:133–40)
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Unstable angina is a diagnosis applied to a heterogeneous
group of patients (1–3). The diagnosis is typically made by the
patient’s description of the character and circumstances of the
chest pain, with some patients developing myocardial necrosis
(i.e., non–Q wave myocardial infarction [MI]) (4). Across this
broad group of patients, usually referred to as having “acute
coronary syndromes,” the risk of subsequent adverse outcome
varies widely (5,6). Accordingly, efforts have been focused on
better identification of high risk patients who need more
aggressive medical and interventional treatment (2). Because
of its universal availability, low cost and simplicity, electrocar-
diography is an attractive method to risk stratify patients.
However, little prospective information is available on its value
in predicting outcome in the current era of aggressive medical
and interventional therapy.
The Thrombolysis in Myocardial Ischemia (TIMI) III Reg-
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istry was a prospective, observational study collecting a wide
variety of data to characterize the various types of patients with
unstable angina and non–Q wave MI and their outcomes (7).
To extend these observations, serial electrocardiograms
(ECGs) were obtained from all patients enrolled in the TIMI
III Registry at nine hospitals participating in the ECG Ancil-
lary Study. The major goal of this ancillary study was to
determine the value of ST segment or T wave changes on a
12-lead ECG in characterizing the outcome of patients with
unstable angina. In addition, the outcomes of two poorly
characterized groups of patients with unstable angina and
non–Q wave MI were prospectively examined—those with
0.5-mm ST segment deviation and those with left bundle
branch block (LBBB). It was hypothesized that these two
groups would constitute high risk groups.
Methods
Patient group. The details of the TIMI III Registry have
been previously reported (7). The study was conducted be-
tween October 1990 and April 1993 at 18 clinical centers in the
United States and Canada, nine of which participated in the
prospective ECG Ancillary Study (see Appendix). The Regis-
try was composed of two parts: The “enumeration roster”
included all consecutive patients admitted with unstable angina
or non–Q wave MI who met the following criteria: Inclusion
criteria 5 the presence of typical chest discomfort (or equiva-
lent) believed to be ischemic in nature, lasting at least 5 min
and occurring within 96 h of (or during) hospital admission,
and having an unstable pattern of pain, consisting of either rest
pain, new onset, severe or frequent angina, accelerating angina
or angina occurring within 21 days after an acute MI. Exclusion
criteria 5 nonischemic or atypical pain, persistent new ST
segment elevation or Q wave MI on presentation or admission
directly for a revascularization procedure.
From the enumeration roster, 404 patients were enrolled in
the concurrent TIMI IIIB trial (5). From the remaining
patients, specific subgroups, characterized by age, gender and
race, were randomly selected for inclusion in the “prospective
study” using a sampling ratio that sought to enroll a larger
proportion of elderly, women and blacks (7). After written
informed consent was obtained, more detailed clinical infor-
mation was collected, including 1-year telephone follow-up for
vital status, which was complete in 96% of patients. The study
was approved by each participating hospital’s Institutional
Review Board.
ECG Ancillary Study. For patients in the “prospective
study,” ECGs were collected in association with the qualifying
episode of ischemic pain, and the most recent ECG before the
qualifying episode of pain (or one 12 to 24 h after if not
available). Each ECG was evaluated in the central ECG core
laboratory by a single electrophysiologist (L.I.G.) who had no
knowledge of the patients’ outcome. The rate, rhythm and
presence of conduction defects, including LBBB (either new or
old), were recorded. In addition, each lead was evaluated
separately for the presence or absence of 1) Q waves .0.03 s
in width and .0.3 mm in depth; 2) the presence and degree of
ST segment deviation (depression or elevation), categorized as
none, 0.5 mm, 1.0 mm, 2.0 mm or .2.0 mm; 3) T wave
deviation, categorized as positive ($1.0 mm), biphasic or with
amplitude ,1.0 mm or negative (inversion $1.0 mm).
Data from the qualifying ECG were compared with the
prequalifying ECG, if available, to categorize the presence on
the qualifying ECG of “new or presumably new” ST segment
deviation or T wave inversion in two or more contiguous leads.
As in TIMI IIIB, the definition of ST segment deviation was
transient or persistent ST segment depression or transient ST
segment elevation (5). Accordingly, in patients with ST seg-
ment elevation on the qualifying ECG, a comparison ECG was
required for inclusion in the analysis.
Of 1,565 patients enrolled in the prospective study at the
participating hospitals, the qualifying ECG was not available in
126, most frequently because it was obtained at a nonpartici-
pating hospital before transfer of the patient to the TIMI III
Registry hospital. In addition, two other groups were prospec-
tively excluded from the ECG analysis: those who began taking
digoxin between the prequalifying and qualifying ECG (n 5 4);
those with apparent ST segment elevation on the qualifying
ECG in whom a comparison baseline ECG was not available
(n 5 16); in addition, three patients were not enrolled in the
ancillary study.
End points. The following end points were evaluated:
1) death; 2) post-enrollment MI as confirmed by a creatine
kinase MB fraction greater than the upper limit of normal (i.e.,
a recurrent MI in patients with evolving non–Q wave MI on
admission) and recurrent ischemia, defined as either in-
hospital ischemic pain at rest associated with ST segment or
T wave changes as assessed by the local investigator; or
3) post–hospital discharge recurrent ischemic pain requiring
readmission to the hospital.
Statistical analyses. To evaluate the relation between
ECG findings on the qualifying ECG and clinical outcomes,
patients were divided into four mutually exclusive groups:
those with LBBB; new or presumably new ST segment devia-
tion $1 mm (in the absence of LBBB); isolated T wave
inversion or pseudonormalization (and no ST segment devia-
tion); or none of these ECG changes. These groups were
compared for their baseline characteristics, in-hospital treat-
ment and outcome. Both the four-way and pairwise compari-
sons were accomplished using the Mantel-Haenszel statistic. In
addition, analysis by a Cox proportional hazards model using
age, gender and race as covariates was performed for clinical
Abbreviations and Acronyms
ECG 5 electrocardiogram, electrocardiographic
LBBB 5 left bundle branch block
MI 5 myocardial infarction
TIMI 5 Thrombolysis in Myocardial Ischemia
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outcomes at 42 days and 1 year to identify multivariate
predictors of outcome.
Kaplan-Meier event rates, percentages and means of base-
line characteristics and outcome data for the patients in the
ECG Ancillary Study were directly adjusted to the age-gender-
race distribution from the enumeration roster (8). That is, the
event rates and proportions were calculated for each age-
gender-race category, and a weighted average of these esti-
mates was calculated. The weights used were proportional to
the number of patients enumerated in each age-gender-race
category. For comparisons of subgroups, chi-square analysis
was used. To adjust for the effects of multiple testing, p values
of 0.01 to 0.001 were considered as providing some evidence of
group differences, and p , 0.001 was considered as providing
strong evidence of group differences.
Results
Distribution of ECG findings. Among the 1,416 patients
with unstable angina or non–Q wave MI in the study, 14.3%
demonstrated new or presumably new ST segment deviation
$1 mm on the qualifying ECG, 9% demonstrated LBBB,
21.9% had T wave changes and 54.9% did not have these ECG
changes. Among patients with ST segment deviation, 23 (1.6%
of the total group) had transient ST segment elevation,
whereas 179 (12.6%) had ST segment depression. Of the
patients with LBBB, only 6 (0.4% of the total group) had
developed a new LBBB at the time of presentation. Using the
sampling ratios in the age-gender-race subgroups of patients in
the prospective study, direct adjusted rates were calculated to
estimate the prevalence of ECG findings in the entire group of
patients admitted to the hospital with unstable angina and
non–Q wave MI (Fig. 1). As shown, a total of 40% of the total
group of patients with unstable angina and non–Q wave MI
demonstrated one of these changes on the qualifying ECG.
Baseline characteristics. Patients with new ST segment
deviation $1 mm were older, but other baseline characteristics
were similar, including gender, race, coronary risk factors,
pattern of angina, history of angina or previous revasculariza-
tion (Table 1). Patients with isolated T wave inversion were
similar in terms of baseline characteristics to those without
ECG changes. Patients in Canada and the United States had a
similar distribution of ECG findings. Two-thirds of patients
had previously been admitted to the hospital for unstable
angina, indicating the recurrent nature of unstable angina.
Previous angina was present in 79% of patients, and nearly
one-quarter had undergone previous coronary artery bypass
graft surgery (Table 1).
Despite the high prevalence of previous coronary artery
disease, only 45% of patients were taking aspirin at the time of
enrollment. Only 27% were receiving beta-blockers, in contrast
to calcium antagonists and nitrates, which were being used in
nearly 50% of patients (Table 1). Rales over more than
one-third of the lung fields ranged from 3% in patients without
ECG changes to 21% in patients with LBBB (p , 0.001). Rest
pain was present in 78% of patients. The rate of non–Q wave
MI on presentation ranged from 19% in patients without ECG
changes to 39% in patients with ST segment deviation $1 mm
(p , 0.001).
In-hospital treatment. Intravenous nitroglycerin and beta-
blockers tended to be prescribed more often in patients with
ST segment deviation. Heparin was used in only 55% of
patients with ST segment deviation (Table 2). Aspirin treat-
ment did not differ by presenting ECG findings, but was used
in only 82% of patients, even in those with ST segment
deviation (79%). Calcium antagonists were used in the major-
ity of patients, more so than beta-blockers.
Cardiac procedures. Cardiac catheterization was per-
formed in two-thirds of patients with ST segment, T wave or no
ECG changes, but in less than half of patients with LBBB
(Table 2). In patients undergoing catheterization, multivessel
disease was found in 66% of patients with ST segment devia-
tion, compared with 40% of patients without ECG changes
(p , 0.001). The absence of significant coronary stenosis
ranged from only 10% of patients with ST segment deviation to
29% of patients without ECG changes to 34% of patients with
LBBB (Table 2).
Revascularization in the hospital was more frequent in
patients with ST segment deviation at presentation, primarily
because of the increased rate of bypass surgery performed in
22% of these patients compared with 9% of patients without
ECG changes (p , 0.001) (Table 2). Interestingly, percutane-
ous transluminal coronary angioplasty was performed at a
similar rate, regardless of the presence or absence of ST
segment or T wave changes, although only 6% of patients with
LBBB underwent coronary angioplasty. After the initial hos-
pital period, only 2% to 3% more patients underwent revas-
cularization through 1 year, indicating that the initial clinical
presentation and ECG findings allowed for accurate triage to
the ultimate treatment strategy. Hospital length of stay for all
patients was relatively long, .1 week on average.
Clinical outcome. Mortality was low overall, ;1% in the
hospital and 2% to 5% by 42 days (Table 2 and 3). By 1-year
Figure 1. Distribution of ECG changes with the qualifying episode of
pain. Rates are the direct-adjusted rates to match the age-gender-race
distribution in the enumeration roster of all consecutive patients
admitted with unstable angina and non–Q wave MI.
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follow-up, the mortality rate had risen to 9.8% in patients with
ST segment deviation $1 mm, compared with 5.5% for
patients with T wave or no ECG changes (p , 0.001) (Table 3).
Death or MI occurred in 11% of patients with ST segment
deviation $1 mm, compared with 7% for those with new,
isolated T wave inversion and 8% for those with no ECG
changes (p , 0.001). The rate of death or MI was not
statistically different between those with T wave inversion and
those with no ECG changes. Patients with LBBB had a very
low rate of death or MI in the hospital (,1%), but by 1-year
follow-up they had the highest rate of death or MI (23%).
Recurrent ischemia (rest pain with ST segment or T wave
changes) occurred in the hospital more frequently (19%) in
patients with ST segment deviation at presentation, compared
with 11% of patients with initial T wave changes and 7.5% of
patients without ECG changes (p , 0.001) (Table 2). Recur-
rent rest pain without ECG changes was common, occurring in
approximately one-third of patients in all groups. Through
1-year follow-up, recurrent angina requiring readmission to the
hospital occurred in ;15% of patients (Table 3). The 1-year
rate of death, MI or recurrent ischemia (with ECG changes or
requiring readmission to the hospital) ranged from 25.5% of
patients without ECG changes on the initial ECG to 36% of
patients with ST segment deviation (p , 0.001).
Location and severity of ECG changes. The difference in
outcome by location of ECG changes is shown in Figure 2.
Among patients with ST segment deviation $1 mm, anterior
changes carried the worst prognosis, with a rate of death or MI
of 12.4% by 1 year, compared with 7% to 8% for other
locations or no ST segment deviation (p 5 0.002). In contrast,
the location of isolated T wave changes was not correlated with
outcome (Fig. 2).
Degree of ST segment deviation and outcome. The prog-
nostic significance of different degrees of ST segment deviation
is shown in Table 4. A total of 187 patients (13% of the total
group) demonstrated 0.5-mm ST segment deviation. The clin-
ical outcome at follow-up was similar or worse for patients with
0.5-mm ST segment deviation than for those with $1 mm:
Death or MI by 1 year occurred in 16% of patients with ST
segment deviation 0.5 mm, compared with 6% of patients
without ST segment deviation and 10% to 15% of patients with
ST segment deviation $1 mm (p , 0.001).
Multivariate predictors of long-term outcome. On multi-
variate analysis, seven variables were identified as independent
predictors of death or MI by 1 year (Table 5). The two ECG
variables were LBBB and ST segment deviation $0.5 mm,
which were each associated with a risk ratio of death or MI at
1 year of 2.80 and 2.45, respectively (each p , 0.001). In
another model, ST segment deviation $1 mm was an indepen-
dent predictor (p , 0.001), but it had a lower risk ratio (1.85)
than ST segment deviation $0.5 mm.
Discussion
In this prospective study of unstable angina and non–Q
wave MI, the admission ECG was a valuable tool in predicting
Table 1. Baseline Characteristics by Electrocardiographic Findings
All Pts
(n 5 1,416)
LBBB
(n 5 127)
ST Dev $1 mm
(n 5 202)
Isolated T Wave
Changes
(n 5 310)
No ECG Changes
(n 5 777)
p Value
Four
Way*
ST vs. No
ST Dev
Mean age (yr) 62.5 65.7 63.9 61.1 59.4 , 0.001 , 0.001
.75 yr (%) 13.8 29.0 23.6 13.7 10.0 , 0.001 , 0.001
% male 58.3 44.6 57.6 57.6 60.4 0.176 0.448
% black 13.2 13.4 12.0 17.6† 11.9 0.03 0.554
Prior hosp for unstable angina 66.3 84.8 72.0 66.7 62.9 0.002 0.04
Prior MI 41.0 55.0 46.3 45.9 36.6 0.001 0.042
Medication in prior week
Aspirin ,24 h 44.6 47.9 47.1 48.9 42.3 0.541 0.191
Heparin 5.2 4.1 9.2 3.6 5.1 0.274 0.077
Warfarin 5.7 12.5 7.9 6.3 4.2 0.033 0.522
Thrombolysis 0.7 0 1.1 0 0.9 0.556 0.872
Nitrates 42.5 54.0 48.6 43.6 39.5 0.001 0.007
Beta-blockers 27.1 14.6 36.0 25.7 27.3 0.008 0.137
Ca-blockers 46.4 36.7 46.0 49.6 46.5 0.248 0.461
ACE inhibitors 17.4 33.9 21.0 19.7 14.0 0.004 0.289
Rales .1/3 lungs 5.8 21.4 9.4 6.6* 2.9 , 0.001 0.02
Acute pulmonary edema 2.4 11.8 5.5 2.1 0.8 , 0.001 0.023
Cardiogenic shock 1.1 0.8 0.2 1.6 1.1 0.743 0.354
Other major illness 9.3 19.5 9.6 10.6 7.5 0.255 0.861
Non-Q wave MI at entry 24.8 31.8 38.8 31.3‡ 18.8 , 0.001 , 0.001
*Mantel-Haenzel statistic comparing all four electrocardiographic (ECG) groups. †p , 0.01, ‡p , 0.001, T wave inversion group versus no ECG changes group;
all other comparisons between these two groups were p 5 NS. Direct adjusted rates controlling for sampling in age, gender and race strata (see Methods). Data
presented are percent of patients (Pts), unless otherwise indicated. ACE 5 angiotensin-converting enzyme; Dev 5 deviation; hosp 5 hospital admission; LBBB 5 left
bundle branch block; MI 5 myocardial infarction.
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outcome. Several groups of patients could be identified as high
risk: patients with ST segment deviation $1 mm, those with
$0.5 mm ST segment deviation and those with LBBB. Inter-
estingly, the presence of isolated T wave changes, even in the
anterior leads, did not appear to influence short- or long-term
prognosis, and thus appears to add little to the clinical
assessment. In contrast, using the new ECG criteria of ST
segment deviation $0.5 mm or LBBB, which identify as “high
risk” nearly one-third of all patients with unstable angina and
non–Q wave MI, the long-term prognosis was poor, with a
15.8% rate of death or MI by 1 year. This highlights the chronic
and recurrent nature of unstable angina and suggests that
attention should be focused on maximizing current medical
therapy for these high risk patients, and should strengthen the
resolve of clinical investigators to find new medical and
interventional treatments for these patients.
ST segment deviation. The presence of transient ST seg-
ment depression or elevation $1 mm has previously been
recognized as a marker of adverse outcome in patients with
unstable angina (9–14). However, prospective, multicenter
data have been sparse in the current era of aggressive man-
agement and combination antithrombotic therapy. In this
large, prospective study, we observed that ST segment devia-
tion remains one of the adverse predictors of subsequent death
or MI by 1-year follow-up. In this cohort, ST segment deviation
heralded more advanced coronary artery disease, including
15% of patients with left main coronary stenosis. These
patients also had nearly twice the rate of non–Q wave MI on
hospital admission compared with patients without ECG
changes (39% vs. 19%, four-way p , 0.001), as was observed in
TIMI IIIB (4).
Current management was relatively aggressive for patients
with ST segment deviation, with intravenous heparin, aspirin,
beta-blockers and intravenous nitrates used in a higher per-
centage of these patients than those with other ECG findings.
However, many gaps appear to exist between current recom-
mendations (15–18) and actual practice, even in the teaching
hospitals that participated in this registry. In this cross section
Table 2. In-Hospital Treatment and Outcome
All Pts
(n 5 1,416)
LBBB
(n 5 127)
ST Dev $1 mm
(n 5 202)
Isolated T Wave
Changes
(n 5 310)
No ECG Changes
(n 5 777)
p Value
Four Way*
ST vs. No
ST Dev
Meds for qualifying event
Aspirin 82.3 82.5 79.0 83.1 82.6 0.776 0.587
Heparin 52.5 51.2 55.4 55.9 51.0 0.062 0.025
IV nitroglycerin 32.6 35.9 44.6 32.2 29.9 , 0.001 , 0.001
Nitrates 72.4 67.2 69.8 70.0 74.4 0.312 0.452
Beta-blockers 38.0 19.2 47.9 38.0 38.2 , 0.001 0.083
Ca-blockers 54.4 38.4 62.1 56.1 54.1 0.013 0.052
ACE inhibitors 17.1 38.4 22.8 16.1 13.8 , 0.001 0.158
Cath performed 62.4 45.4 66.6 65.6 62.5 0.003 0.03
0 VD 24.0 33.5 10.4 16.7 29.1
1 VD 30.1 29.6 23.3 32.9 30.7 , 0.001 , 0.001
2 VD 22.2 14.7 32.7 25.8 19.1
3 VD 23.7 22.2 33.9 24.6 21.1
LMCA stenosis 7.4 4.7 15.3 7.6 5.7 0.016 0.019
PTCA 20.3 5.8 23.5 22.4 20.6 0.095 0.582
CABG 11.5 7.6 21.8 14.6 8.7 , 0.001 , 0.001
PTCA or CABG 31.1 11.9 45.3 36.1 28.7 , 0.001 0.001
In-hospital event
Death 0.6 0.3 1.4 1.0 0.4 0.112 0.033
MI 1.4 0.4 1.7 1.3 1.5 0.477 0.391
Death or MI 1.8 0.8 2.6 1.6 1.6 0.203 0.091
Ischemia with ECG
changes
9.5 5.6 18.2 11.4 7.5 , 0.001 , 0.001
Death/MI/ischemia with
ECG changes
10.5 6.4 20.2 12.6 8.3 , 0.001 , 0.001
Ischemia without ECG
changes
31.6 37.0 31.2 31.6 31.0 0.399 0.937
Length of stay (days) 8.9 8.5 9.9 9.6† 7.5 , 0.001‡ , 0.001
*Mantel-Haenzel statistic comparing all four electrocardiographic (ECG) groups. †p , 0.001 comparing T wave inversion group versus no ECG changes; all other
comparisons of these two groups were p 5 NS. ‡For length of stay, the four-way p value was obtained from an F test statistic comparing the mean values among four
groups, controlling for age, gender and race. Direct adjusted rates controlling for sampling in age, gender and race strata (see Methods). Data are percent of patients.
Two-way p value obtained from a t test statistic comparing the mean values between the two groups, controlling for age, gender and race. CABG 5 coronary artery
bypass grafting; Cath 5 catheterization, IV 5 intravenous; LMCA 5 left main coronary artery; Meds 5 medications; PTCA 5 percutaneous transluminal coronary
angioplasty; VD 5 vessel disease; other abbreviations as in Table 1.
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of clinical practice, nearly 20% of patients with ST segment
deviation were not treated with aspirin, despite the overwhelm-
ing evidence supporting its benefit in this patient group
(15,16,18–20). Although less firmly established, several studies
have suggested that intravenous heparin is beneficial in unsta-
ble angina and non–Q wave MI (17,18,21), yet it was used in
only 51% of patients, even if ST segment deviation was present
on hospital admission. These data suggest that significant
opportunities exist for improvement in the management (and
thus outcome) of patients with unstable angina and non–Q
wave MI, and that if currently available therapies such as
aspirin, heparin and beta-blockers are used more consistently,
a significant number of lives would be saved each year.
Degree of ST segment deviation. Although ST segment
deviation $1 mm is associated with an adverse prognosis
(9–14), as recently confirmed in the TIMI IIIB trial (5), it has
not been clear whether the presence of 0.5-mm ST segment
deviation is a nonspecific finding (as it is in exercise testing)
(22) or a reliable marker of adverse clinical outcome. We
observed that patients with unstable angina and non–Q wave
MI presenting with only 0.5-mm ST segment deviation have an
adverse early and late outcome, similar or worse than that of
patients with ST segment deviation $1 mm. On multivariate
analysis, it was an independent predictor of 1-year outcome.
Thus, on admission ECGs, the presence of 0.5-mm ST segment
deviation appears to indicate a true ischemic ECG change that
is associated with an adverse prognosis. For clinicians, the
presence of this degree of ST segment deviation (and not T
wave changes) should signal the need for vigilance and aggres-
sive management. These data also support the use of $0.5-mm
ST segment deviation as an entry criterion for clinical trials of
unstable angina and non–Q wave MI.
Left bundle branch block. Although patients with LBBB
have recently been identified to be at high risk after acute MI
in thrombolytic trials (23,24), their outcome has not been well
characterized when presenting with a self-limited episode of
ischemic pain. We observed that LBBB comprised 7% of the
overall group of patients (and 15% of patients .75 years old).
Patients with LBBB had more evidence of left ventricular
failure, with 34% taking angiotensin-converting enzyme inhib-
itors at baseline, and over 20% having congestive heart failure
Figure 2. Relation between location of ECG changes and 1-year death
or MI. Rates are adjusted Kaplan-Meier event rates. Left, ST segment
deviation; right, T wave inversion (includes only those patients with
isolated T wave inversion.)
Table 3. Adjusted 42-Day and 1-Year Kaplan-Meier Event Rates
All Pts
(n 5 1,416)
LBBB
(n 5 127)
ST Dev $1 mm
(n 5 202)
Isolated T Wave
Changes
(n 5 310)
No ECG Changes
(n 5 777)
p Value
Four Way*
ST vs. No
ST Dev
42-day event rates
Death 2.4 5.2 2.5 2.8 1.8 0.198 0.091
MI 2.2 1.8 1.5 2.4 2.3 0.725 0.41
Death or MI 4.0 6.6 3.6 3.7 3.7 0.443 0.123
Rehosp for rest angina 5.3 6.7 7.3 5.6 4.5 0.13 0.032
Death, MI or rec isch 16.1 14.2 23.6 17.9 13.9 , 0.001 , 0.001
PTCA 20.7 3.4 24.9 23.9 20.4 0.024 0.538
CABG 13.4 10.5 25.8 16.3 10.7 , 0.001 , 0.001
PTCA or CABG 33.4 12.6 50.8 39.3 30.4 , 0.001 0.001
1-yr event rates
Death 7.2 18.2 9.8 5.6 5.5 , 0.001 , 0.001
MI 4.0 6.3 6 3.7 3.5 0.446 0.13
Death or MI 9.5 22.9 11 6.8 8.2 , 0.001 0.001
Rehosp for rest angina 15.9 13.4 17.7 16.8 15.4 0.753 0.293
Death, MI or rec isch 28.3 34.0 36.1 30.4 25.5 0.003 0.001
PTCA 22.9 7.6 25.3 26.2 22.8 0.037 0.621
CABG 16.1 10.8 27.2 17.9 14.3 0.004 0.002
PTCA or CABG 36.4 16.6 51.1 42.3 33.9 , 0.001 0.001
*Mantel-Haenzel statistic comparing all four electrocardiographic (ECG) groups; p value obtained from Cox proportional hazards analysis with age, gender and
race included. All comparisons between T wave inversion group and no ECG changes were p 5 NS. rec isch 5 recurrent ischemia with ECG changes or requiring
admission to the hospital; other abbreviations as in Tables 1 and 2.
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at presentation. Although fewer patients underwent cardiac
catheterization, of those who did, .34% had no significant
coronary stenoses, indicating possible misdiagnosis or the
concomitant presence of cardiomyopathy. They were managed
more conservatively in the hospital, with a lower rate of
revascularization. However, during follow-up their mortality
rate was 18% by 1 year, nearly double that of patients
presenting with ST segment deviation. As such, this group of
patients deserves careful attention and potentially more ag-
gressive medical management.
Implications for clinical trials. The major implication of
this analysis for clinical trials, which usually focus on high risk
patients, is that a much more accurate assessment of risk can
be made using different ECG criteria than those in current
practice. Although isolated T wave inversion clearly represents
an ECG change, it appears not to be a marker of adverse
prognosis (Table 3). Thus, the use of isolated T wave inversion
as an entry criterion would select relatively low risk patients.
Using the standard criterion of ST segment deviation $1 mm
or T wave inversion to select a “high risk” patient group, the
1-year rate of death or MI in this cohort was 8.5%. If one
restricted this to only ST segment deviation $1 mm, the event
rate would be higher (11%), but it would comprise only 12% of
the total group. With the new criteria identified in this
analysis—ST segment deviation $0.5 mm or LBBB—the pool
of patients who fall into a truly high risk group is greatly
expanded to nearly one-third the entire group of patients with
unstable angina and non–Q wave MI, and their 1-year event
rate was 15.8%.
Study limitations. The ECG interpretations in this study
were not carried out using the Minnesota code, which has been
used extensively (25,26). However, the Minnesota code is
complex and not used clinically, whereas the coding used in
this study is similar to that used in clinical cardiology, making
the findings in this study all the more useful clinically. Inter-
pretation of the ECGs was done by visual inspection, and not
by tracing the ECGs, and computerized enhancement was
done as in TIMI IIIB (5). However, the ECG interpretation
was carried out by a single electrophysiologist who had no
knowledge of the clinical characteristics and outcome, thereby
adding standardization to the ECG findings. Finally, this study
is an observational study, and as such, the treatment strategies
employed by physicians were not standardized. However, this
is a multicenter study with careful screening and follow-up of
all consecutive patients to avoid any selection or reporting bias,
thus giving an accurate picture of clinical outcomes in current
practice.
Conclusions. The ECG remains one of the most useful and
cost-effective tools in the evaluation of patients with unstable
angina and non–Q wave MI. A group of patients with unstable
angina and non–Q wave MI at high risk for adverse outcome
(15.8% death or MI by 1 year) can be identified not only by the
presence of ST segment deviation $1 mm, but also by ST
segment deviation $0.5 mm or LBBB at the time of presen-
tation (together comprising over one-third of all patients). In
contrast, isolated T wave inversion did not influence outcome,
suggesting that clinicians should focus less on T waves and
more on subtle degrees of ST segment deviation. Our data
highlight the chronic and recurrent nature of unstable angina
and the need for improved application of currently available
medical treatments and a search for more effective therapies
for these high risk patients.
Appendix
TIMI III Registry ECG Ancillary Study Group
TIMI Study Chairman’s Office: Eugene Braunwald, MD, Study Chairman;
Co-Investigators: Christopher P. Cannon, MD, Peter H. Stone, MD, Carolyn H.
McCabe, BS; Data Coordinating Center: Genell L. Knatterud, PhD, Principal
Investigator; Bruce W. Thompson, PhD, Co-Principal Investigator; Co-
Investigators: Joyce Depkin, BS, Martha Canner, MS, Patricia Wilkins, BS,
Rosemary Giro, Mark Schactman, MS; ECG Core Laboratory: Christopher P.
Cannon, MD, Principal Investigator; Leonard I. Ganz, MD, Co-Investigator.
Table 4. Relation of Degree of ST Segment Deviation and Outcome*
Degree of ST Segment Deviation
$2 mm
(n 5 63)
1 mm
(n 5 139)
0.5 mm
(n 5 187)
None
(n 5 900)
p
Value†
Death by 42 d 0.8 3.0 7.1 1.1 0.002
Death or MI by 42 d 2.8 3.4 10.7 2.4 0.001
Death, MI, RI by 42 d 19.5 22.7 25.8 13.0 , 0.001
Death or MI by 1 yr 14.9 9.7 16.3 6.1 , 0.001
*Adjusted Kaplan-Meier event rates. †Cox proportional hazards model. d 5 days; RI 5 recurrent ischemia with
electrocardiographic changes in hospital or requiring admission to hospital; other abbreviations as in Table 1.
Table 5. Multivariate Predictors of Death or Myocardial Infarction
at One Year for 1,411 Patients
Characteristic RR (95% CI) p Value*
Age (decade) 1.43 (1.26–1.61) , 0.001
Thrombolysis in prior wk 9.40 (2.94–30.01) , 0.001
LBBB 2.80 (1.81–4.32) , 0.001
ST Dev $0.5 mm 2.45 (1.74–3.45) , 0.001
Other major illness 1.94 (1.33–2.84) , 0.001
TIMI IIIB exclusion: unable to comply
with follow-up
5.61 (1.74–18.06) 0.004
Nitrates in prior wk 1.60 (1.16–2.20) 0.004
*Cox proportional hazards analysis. CI 5 confidence interval; RR 5 risk
ratio; TIMI 5 Thrombolysis in Myocardial Ischemia; other abbreviations as in
Table 1.
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Clinical Centers
Brigham and Women’s Hospital, Boston, Massachusetts: Peter H. Stone,
MD, Principal Investigator; Co-Investigators: Christopher P. Cannon, MD, Nancy
Cummings, RN; Beth Israel Hospital, Boston, Massachusetts: Daniel J. Diver,
MD, Principal Investigator; Co-Investigators: Donald S. Baim, MD, Joseph
Carozza, MD, Susan Marble, MS, RN, Ann Slater, RN; University of Alabama
at Birmingham, Birmingham, Alabama: William J. Rogers, MD, Principal
Investigator; Co-Investigators: William A. Baxley, MD, Larry S. Dean, MD, Vera
A. Bittner, MD, Louis J. Dell’Italia, MD, Jerri Moody, RN, Cynthia Weeks.
University of Chicago Hospitals, Chicago, Illinois: Ted Feldman, MD, Principal
Investigator; Co-Investigators: Matthew J. Sorrentino, MD, Anne Pastoret, RN,
Sharon Holloway, RN, MSN; University of North Carolina, Chapel Hill, North
Carolina: Marcus Williams, MD, Principal Investigator; Co-Investigators: Gregory
J. Dehmer, MD, David A. Tate, MD, Mary Jackson, RN, MSN; University of
Texas Health Science Center at Houston, Houston, Texas: James T. Willerson,
MD, Principal Investigator; H. Vernon Anderson, MD, Co-Principal Investigator;
Co-Investigators: Louise Jones, RN, Lynette Weigelt, RN; University of Texas
Medical Branch at Galveston, Galveston, Texas: Marvin W. Kronenberg, MD,
Principal Investigator; Co-Investigators: Michael J. Davis, MD, Robert W. Farrell,
MD, M. Amir Ibrahim, MD, John F. Schmedtje, Jr., MD, MPH; University of
Virginia, Charlottesville, Virginia: Robert S. Gibson, MD, Principal Investigator;
Co-Investigators: Eric R. Powers, MD, Lawrence R. Burwell, MD, Ian J.
Sarembock, MD, Christine M. Gasperetti, MD, Denny D. Watson, MD, Sharon
L. Sayre, BSN, Nancy M. Fauber, MSN, Margaret W. Ball, BSN; Victoria
General Hospital, Halifax, Nova Scotia, Canada: Catherine M. Kells, MD,
Principal Investigator; Co-Investigators: David Johnstone, MD, Theresa Fawcett,
RN, Vivian Nedelcu.
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